NASDAQ:NERV
Minerva Neurosciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.minervaneurosciences.comipo date
Jul 01, 2014
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus